img

Global Ciclesonide Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Ciclesonide Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Ciclesonide is a glucocorticoid used to treat asthma and allergic rhinitis. It is marketed under the brand names Alvesco for asthma and Omnaris, Omniair, and Zetonna for hay fever in the US and Canada.
Ciclesonide report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ciclesonide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Adults and Children are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ciclesonide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Ciclesonide key companies include Covis Pharma. etc. Covis Pharma, , are top 3 players and held % share in total in 2022.
Ciclesonide can be divided into Inhalation Aerosol 37 mcg/actuation, Inhalation Aerosol 80 mcg/actuation, Inhalation Aerosol 120 mcg/actuation and Inhalation Aerosol 160 mcg/actuation, etc. Inhalation Aerosol 37 mcg/actuation is the mainstream product in the market, accounting for % share globally in 2022.
Ciclesonide is widely used in various fields, such as Adults and Children, etc. Adults provides greatest supports to the Ciclesonide industry development. In 2022, global % share of Ciclesonide went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ciclesonide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Covis Pharma
Segment by Type
Inhalation Aerosol 37 mcg/actuation
Inhalation Aerosol 80 mcg/actuation
Inhalation Aerosol 120 mcg/actuation
Inhalation Aerosol 160 mcg/actuation

Segment by Application


Adults
Children
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ciclesonide market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Ciclesonide introduction, etc. Ciclesonide Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Ciclesonide market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of Ciclesonide
1.1 Ciclesonide Market Overview
1.1.1 Ciclesonide Product Scope
1.1.2 Ciclesonide Market Status and Outlook
1.2 Global Ciclesonide Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Ciclesonide Market Size by Region (2018-2034)
1.4 Global Ciclesonide Historic Market Size by Region (2018-2024)
1.5 Global Ciclesonide Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Ciclesonide Market Size (2018-2034)
1.6.1 North America Ciclesonide Market Size (2018-2034)
1.6.2 Europe Ciclesonide Market Size (2018-2034)
1.6.3 Asia-Pacific Ciclesonide Market Size (2018-2034)
1.6.4 Latin America Ciclesonide Market Size (2018-2034)
1.6.5 Middle East & Africa Ciclesonide Market Size (2018-2034)
2 Ciclesonide Market by Type
2.1 Introduction
2.1.1 Inhalation Aerosol 37 mcg/actuation
2.1.2 Inhalation Aerosol 80 mcg/actuation
2.1.3 Inhalation Aerosol 120 mcg/actuation
2.1.4 Inhalation Aerosol 160 mcg/actuation
2.2 Global Ciclesonide Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Ciclesonide Historic Market Size by Type (2018-2024)
2.2.2 Global Ciclesonide Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Ciclesonide Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Ciclesonide Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Ciclesonide Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Ciclesonide Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Ciclesonide Revenue Breakdown by Type (2018-2034)
3 Ciclesonide Market Overview by Application
3.1 Introduction
3.1.1 Adults
3.1.2 Children
3.2 Global Ciclesonide Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Ciclesonide Historic Market Size by Application (2018-2024)
3.2.2 Global Ciclesonide Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Ciclesonide Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Ciclesonide Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Ciclesonide Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Ciclesonide Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Ciclesonide Revenue Breakdown by Application (2018-2034)
4 Ciclesonide Competition Analysis by Players
4.1 Global Ciclesonide Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ciclesonide as of 2022)
4.3 Date of Key Players Enter into Ciclesonide Market
4.4 Global Top Players Ciclesonide Headquarters and Area Served
4.5 Key Players Ciclesonide Product Solution and Service
4.6 Competitive Status
4.6.1 Ciclesonide Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Covis Pharma
5.1.1 Covis Pharma Profile
5.1.2 Covis Pharma Main Business
5.1.3 Covis Pharma Ciclesonide Products, Services and Solutions
5.1.4 Covis Pharma Ciclesonide Revenue (US$ Million) & (2018-2024)
5.1.5 Covis Pharma Recent Developments
6 North America
6.1 North America Ciclesonide Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Ciclesonide Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Ciclesonide Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Ciclesonide Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Ciclesonide Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Ciclesonide Market Dynamics
11.1 Ciclesonide Industry Trends
11.2 Ciclesonide Market Drivers
11.3 Ciclesonide Market Challenges
11.4 Ciclesonide Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Ciclesonide Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Ciclesonide Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Ciclesonide Market Size Share by Region (2018-2024)
Table 4. Global Ciclesonide Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Ciclesonide Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Ciclesonide Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Ciclesonide Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Ciclesonide Revenue Market Share by Type (2018-2024)
Table 9. Global Ciclesonide Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Ciclesonide Revenue Market Share by Type (2024-2034)
Table 11. North America Ciclesonide Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Ciclesonide Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Ciclesonide Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Ciclesonide Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Ciclesonide Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Ciclesonide Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Ciclesonide Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Ciclesonide Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Ciclesonide Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Ciclesonide Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Ciclesonide Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Ciclesonide Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Ciclesonide Revenue Market Share by Application (2018-2024)
Table 24. Global Ciclesonide Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Ciclesonide Revenue Market Share by Application (2024-2034)
Table 26. North America Ciclesonide Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Ciclesonide Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Ciclesonide Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Ciclesonide Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Ciclesonide Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Ciclesonide Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Ciclesonide Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Ciclesonide Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Ciclesonide Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Ciclesonide Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Ciclesonide Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Ciclesonide Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ciclesonide as of 2022)
Table 39. Date of Key Players Enter into Ciclesonide Market
Table 40. Global Ciclesonide Key Players Headquarters and Area Served
Table 41. Ciclesonide Product Solution and Service
Table 42. Global Ciclesonide Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Covis Pharma Basic Information List
Table 45. Covis Pharma Description and Business Overview
Table 46. Covis Pharma Ciclesonide Products, Services and Solutions
Table 47. Revenue (US$ Million) in Ciclesonide Business of Covis Pharma (2018-2024)
Table 48. Covis Pharma Recent Developments
Table 49. North America Ciclesonide Market Size by Country (2018-2024) & (US$ Million)
Table 50. North America Ciclesonide Market Size by Country (2024-2034) & (US$ Million)
Table 51. Europe Ciclesonide Market Size by Country (2018-2024) & (US$ Million)
Table 52. Europe Ciclesonide Market Size by Country (2024-2034) & (US$ Million)
Table 53. Asia-Pacific Ciclesonide Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 54. Asia-Pacific Ciclesonide Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia-Pacific Ciclesonide Market Size by Region (2024-2034) & (US$ Million)
Table 56. Asia-Pacific Ciclesonide Market Share by Region (2018-2024)
Table 57. Asia-Pacific Ciclesonide Market Share by Region (2024-2034)
Table 58. Latin America Ciclesonide Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 59. Latin America Ciclesonide Market Size by Country (2018-2024) & (US$ Million)
Table 60. Latin America Ciclesonide Market Size by Country (2024-2034) & (US$ Million)
Table 61. Middle East & Africa Ciclesonide Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 62. Middle East & Africa Ciclesonide Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East & Africa Ciclesonide Market Size by Country (2024-2034) & (US$ Million)
Table 64. Ciclesonide Market Trends
Table 65. Ciclesonide Market Drivers
Table 66. Ciclesonide Market Challenges
Table 67. Ciclesonide Market Restraints
Table 68. Research Programs/Design for This Report
Table 69. Key Data Information from Secondary Sources
Table 70. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ciclesonide Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Ciclesonide Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Ciclesonide Market Share by Regions: 2022 VS 2034
Figure 4. Global Ciclesonide Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Ciclesonide Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Ciclesonide Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Ciclesonide Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Ciclesonide Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Ciclesonide Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of Inhalation Aerosol 37 mcg/actuation
Figure 11. Global Inhalation Aerosol 37 mcg/actuation Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Inhalation Aerosol 80 mcg/actuation
Figure 13. Global Inhalation Aerosol 80 mcg/actuation Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of Inhalation Aerosol 120 mcg/actuation
Figure 15. Global Inhalation Aerosol 120 mcg/actuation Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Product Picture of Inhalation Aerosol 160 mcg/actuation
Figure 17. Global Inhalation Aerosol 160 mcg/actuation Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 18. Global Ciclesonide Market Size Share by Type: 2022 & 2034
Figure 19. North America Ciclesonide Revenue Market Share by Type (2018-2034)
Figure 20. Europe Ciclesonide Revenue Market Share by Type (2018-2034)
Figure 21. Asia-Pacific Ciclesonide Revenue Market Share by Type (2018-2034)
Figure 22. Latin America Ciclesonide Revenue Market Share by Type (2018-2034)
Figure 23. Middle East and Africa Ciclesonide Revenue Market Share by Type (2018-2034)
Figure 24. Adults Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 25. Children Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 26. Global Ciclesonide Market Size Share by Application: 2022 & 2034
Figure 27. North America Ciclesonide Revenue Market Share by Application (2018-2034)
Figure 28. Europe Ciclesonide Revenue Market Share by Application (2018-2034)
Figure 29. Asia-Pacific Ciclesonide Revenue Market Share by Application (2018-2034)
Figure 30. Latin America Ciclesonide Revenue Market Share by Application (2018-2034)
Figure 31. Middle East and Africa Ciclesonide Revenue Market Share by Application (2018-2034)
Figure 32. Ciclesonide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 33. Global Top 5 and Top 10 Players Ciclesonide Market Share in 2022
Figure 34. North America Ciclesonide Market Share by Country (2018-2034)
Figure 35. U.S. Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 36. Canada Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 37. Germany Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 38. France Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 39. U.K. Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 40. Italy Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 41. Russia Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 42. Nordic Countries Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 43. Asia-Pacific Ciclesonide Market Share by Region (2018-2034)
Figure 44. China Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 45. Japan Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 46. South Korea Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 47. Southeast Asia Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 48. India Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 49. Australia Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 50. Latin America Ciclesonide Market Share by Country (2018-2034)
Figure 51. Mexico Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 52. Brazil Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 53. Middle East & Africa Ciclesonide Market Share by Country (2018-2034)
Figure 54. Turkey Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 56. UAE Ciclesonide Market Size (2018-2034) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries